EVGN logo

EVGN Evogene Ltd.

NASDAQ Global Market · Biotechnology · Healthcare

$0.32
+0.00 (+1.02%)

Evogene Ltd. is a computational biology firm specializing in the identification and advancement of products across human health and agricultural sectors. Its proprietary Computational Predictive Biology (CPB) platform leverages deep biological insights, big data, and artificial intelligence to precisely uncover and guide the creation of life science solutions, including novel microbes, small molec…

Market Cap: $2.72Mwww.evogene.com

Price

No data yet.

Social Signal Score

43
5d
49
3 mentions
—
30d
42
7 mentions
—
60d
39
9 mentions
—
90d
42
13 mentions
—
news: 13

Analyst Ratings

4 analysts
Buyconsensus
Strong Buy 0Buy 4Hold 0Sell 0Strong Sell 0
Avg price target$2.15+579.9%
Low $2.15Median $2.15High $2.15
Current Consensus

Revenue

$141.0K-88.05%
$75.0K$1.45M$2.82M$4.19M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$-0.62
$-0.62–$-0.62
1 analysts
FY2026
$-1.10
$-1.10–$-1.10
1 analysts
FY2027
$-0.60
$-0.60–$-0.60
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Ofer Haviv
Sector
Healthcare
Industry
Biotechnology
Employees
52
Beta
0.68
Country
IL
Piotroski score
1 / 9 (Weak)
Altman Z-score
-34.92
www.evogene.com